| Bautista Medical Group Southern California, Inc. | |
|
427 Central Ave Fillmore CA 93015 | |
| (805) 524-0777 | |
| (805) 524-0111 |
| Full Name | Bautista Medical Group Southern California, Inc. |
|---|---|
| Speciality | Family Medicine |
| Location | 427 Central Ave, Fillmore, California |
| Authorized Official Name and Position | Jose Luis Bautista (INTERNIST) |
| Authorized Official Contact | 8055242559 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Bautista Medical Group Southern California, Inc. 427 Central Ave Fillmore CA 93015-1329 Ph: (805) 524-2559 | Bautista Medical Group Southern California, Inc. 427 Central Ave Fillmore CA 93015 Ph: (805) 524-0777 |
| NPI Number | 1629101340 |
|---|---|
| Provider Enumeration Date | 03/13/2007 |
| Last Update Date | 01/31/2023 |
| Medicare PECOS PAC ID | 6406801604 |
|---|---|
| Medicare Enrollment ID | O20050321000980 |
News Archive
Researchers in Family and Community Medicine at Thomas Jefferson University recently found that obesity was linked to higher rates of prostate cancer screening across all races/ethnic differences and lower rates of cervical cancer screening, most notably in white women.
Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research published in the journal Acta Oncologica.
LDR, a privately held company with innovative spinal implants for both non-fusion and fusion applications, reached the critical 24-month follow-up phase for the one-level IDE study on its second generation Mobi-C® cervical artificial disc. LDR is the first and currently the only company to have completed enrollment for a concurrent one-level and two-level cervical artificial disc replacement study. LDR completed 1-Level enrollment in October 2007 and 2-Level enrollment in March 2008.
EarlySense announced today that its EverOn Touch system has been cleared for marketing by the U.S. Food and Drug Administration. The FDA clearance covers several key additions to the traditional EverOn contact-free patient supervision system value proposition. For the first time, the EverOn system includes an online display that alerts medical staff regarding a patient's motion level and verifies patient turns as indicated by nurses. Identifying low patient movement and then turning patients methodically are key elements in the prevention of pressure ulcers, the most costly patient safety risk in U.S. hospitals.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629101340 | NPI | - | NPPES |
| GR0063042 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A43293 (California) | Primary |
| 207Q00000X | Family Medicine | PA15385 (California) | Secondary |
| 207Q00000X | Family Medicine | A97270 (California) | Secondary |
| Provider Name | Luis Bautista |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1295712206 PECOS PAC ID: 2668505785 Enrollment ID: I20100727000116 |
News Archive
Researchers in Family and Community Medicine at Thomas Jefferson University recently found that obesity was linked to higher rates of prostate cancer screening across all races/ethnic differences and lower rates of cervical cancer screening, most notably in white women.
Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research published in the journal Acta Oncologica.
LDR, a privately held company with innovative spinal implants for both non-fusion and fusion applications, reached the critical 24-month follow-up phase for the one-level IDE study on its second generation Mobi-C® cervical artificial disc. LDR is the first and currently the only company to have completed enrollment for a concurrent one-level and two-level cervical artificial disc replacement study. LDR completed 1-Level enrollment in October 2007 and 2-Level enrollment in March 2008.
EarlySense announced today that its EverOn Touch system has been cleared for marketing by the U.S. Food and Drug Administration. The FDA clearance covers several key additions to the traditional EverOn contact-free patient supervision system value proposition. For the first time, the EverOn system includes an online display that alerts medical staff regarding a patient's motion level and verifies patient turns as indicated by nurses. Identifying low patient movement and then turning patients methodically are key elements in the prevention of pressure ulcers, the most costly patient safety risk in U.S. hospitals.
› Verified 6 days ago
News Archive
Researchers in Family and Community Medicine at Thomas Jefferson University recently found that obesity was linked to higher rates of prostate cancer screening across all races/ethnic differences and lower rates of cervical cancer screening, most notably in white women.
Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research published in the journal Acta Oncologica.
LDR, a privately held company with innovative spinal implants for both non-fusion and fusion applications, reached the critical 24-month follow-up phase for the one-level IDE study on its second generation Mobi-C® cervical artificial disc. LDR is the first and currently the only company to have completed enrollment for a concurrent one-level and two-level cervical artificial disc replacement study. LDR completed 1-Level enrollment in October 2007 and 2-Level enrollment in March 2008.
EarlySense announced today that its EverOn Touch system has been cleared for marketing by the U.S. Food and Drug Administration. The FDA clearance covers several key additions to the traditional EverOn contact-free patient supervision system value proposition. For the first time, the EverOn system includes an online display that alerts medical staff regarding a patient's motion level and verifies patient turns as indicated by nurses. Identifying low patient movement and then turning patients methodically are key elements in the prevention of pressure ulcers, the most costly patient safety risk in U.S. hospitals.
› Verified 6 days ago
Fillmore Family Medical Group Fqhc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 828 W Ventura St Ste 100, Fillmore, CA 93015 Phone: 805-524-2000 | |
Sespe Medical, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 552 Sespe Ave, Fillmore, CA 93015 Phone: 805-524-2559 Fax: 805-524-2596 | |
Cmh Centers For Family Health Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 852 W Ventura St, Fillmore, CA 93015 Phone: 805-524-2672 Fax: 805-524-3953 | |
Christine Marie Johnston Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 552 Sespe Ave Ste C, Fillmore, CA 93015 Phone: 805-524-2000 Fax: 805-524-9601 | |
Mikael Hakansson, M.d. Corp. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 533 Sespe Ave Ste C, Fillmore, CA 93015 Phone: 805-524-2749 Fax: 805-524-6929 | |
Razi Apothecary, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 552 Sespe Ave, Fillmore, CA 93015 Phone: 805-419-2686 | |
Quik Care Medical Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 427 Central Ave, Fillmore, CA 93015 Phone: 805-524-2559 Fax: 805-524-2596 |